Imanova Limited is a pioneering joint venture with exceptional expertise in imaging sciences, vital for disease comprehension and advancement in drug development. Founded in 2011, it is backed by eminent institutions such as the UK's Medical Research Council, Imperial College London, King’s College London, and University College London. Notably, UCLB facilitated its Seed Round investment on 01 January 2012. Imnova's proficiency in drug development, combined with extensive imaging experience, accelerates the development pipeline. With deep-rooted academic knowledge and strong connections to clinicians and scientists at its shareholder institutions, Imnova offers unparalleled capabilities for advancing drug development.
No recent news or press coverage available for Imanova Limited.